Clinical trial
Phase I Trial of S-1153 in Patients With HIV Infection
NCT00002214 is registered in ClinicalTrials.gov with Lexigen Pharmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase I Trial of S-1153 in Patients With HIV Infection
- Lead sponsor
- Lexigen Pharmaceuticals
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- Not reported
- Completion date
- Not reported
- Enrollment
- 40
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.